CHRS
Coherus BioSciences Inc
Price:  
1.70 
USD
Volume:  
1,866,563.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CHRS EV/EBITDA

-1025.4%
Upside

As of 2024-12-11, the EV/EBITDA ratio of Coherus BioSciences Inc (CHRS) is -3.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CHRS's latest enterprise value is 362.68 mil USD. CHRS's TTM EBITDA according to its financial statements is -116.10 mil USD. Dividing these 2 quantities gives us the above CHRS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.1x - 16.5x 11.8x
Forward P/E multiples 11.4x - 24.0x 16.6x
Fair Price (12.92) - (18.08) (15.73)
Upside -859.8% - -1163.3% -1025.4%
1.70 USD
Stock Price
(15.73) USD
Fair Price

CHRS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-06 -3.12
2024-12-05 -2.94
2024-12-04 -3.13
2024-12-03 -3.13
2024-12-02 -2.80
2024-11-29 -2.65
2024-11-27 -2.69
2024-11-26 -2.71
2024-11-25 -2.64
2024-11-22 -2.52
2024-11-21 -2.53
2024-11-20 -2.53
2024-11-19 -2.25
2024-11-18 -2.21
2024-11-15 -2.18
2024-11-14 -2.20
2024-11-13 -2.21
2024-11-12 -2.25
2024-11-11 -2.21
2024-11-08 -2.25
2024-11-07 -2.25
2024-11-06 -2.16
2024-11-05 -2.16
2024-11-04 -2.10
2024-11-01 -2.15
2024-10-31 -2.18
2024-10-30 -2.18
2024-10-29 -2.17
2024-10-28 -2.15
2024-10-25 -2.21
2024-10-24 -2.22
2024-10-23 -2.24
2024-10-22 -2.29
2024-10-21 -2.31
2024-10-18 -2.31
2024-10-17 -2.28
2024-10-16 -2.32
2024-10-15 -2.34
2024-10-14 -2.37
2024-10-11 -2.42
2024-10-10 -2.40
2024-10-09 -2.43
2024-10-08 -2.47
2024-10-07 -2.50
2024-10-04 -2.47
2024-10-03 -2.47
2024-10-02 -2.45
2024-10-01 -2.45
2024-09-30 -2.47
2024-09-27 -2.48